ConductScience.org, home

Paper37795665

Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis.

Gargiulo L and 6 others. J Eur Acad Dermatol Venereol, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis. Papers, record 37795665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37795665

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis.
PubMed
Journal
J Eur Acad Dermatol Venereol
PubMed
Year
2024
PubMed
Publication types
Letter
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.79, provisional
iCite
Revised in PubMed
2024-02-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gargiulo LLhttps://orcid.org/0000-0002-6051-1676
2Ibba LLhttps://orcid.org/0000-0002-7876-4866
3Fiorillo GGhttps://orcid.org/0000-0002-3089-4362
4Valenti MM
5Sierzputowska PP
6Costanzo AAhttps://orcid.org/0000-0001-9697-2557
7Narcisi AA

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pregnancy OutcomeMajor topic
Dermatitis, AtopicMajor topic
Female
Pregnancy
Humans
Heterocyclic Compounds, 3-Ring

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42908038Pregnancy outcome after first-trimester exposure to JAK inhibitors - an evaluation of the German Embryotox cohort.BMC Pharmacol Toxicol2026https://conductscience.org/library/papers/42908038PubMed
42436912Tofacitinib exposure across 2 pregnancies in alopecia universalis: Case report and literature review of Janus kinase inhibitors in pregnancy.JAAD Case Rep2026https://conductscience.org/library/papers/42436912PubMed
40947808Successful pregnancy in a patient with active Crohn's disease, chronic intestinal failure, and long-term parenteral nutrition receiving upadacitinib: A case report.JPEN J Parenter Enteral Nutr2025https://conductscience.org/library/papers/40947808PubMed
39351053Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management.World J Gastroenterol2024https://conductscience.org/library/papers/39351053PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37795665

GET https://conductscience.org/api/papers/v1/37795665/authors